Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2010
04/07/2010CN1813753B Low dose entecavir formulation and use
04/07/2010CN1769298B Fusion protein with antitumour action and its coding gene and uses
04/07/2010CN1764472B Injectable vaccines against multiple meningococcal serogroups
04/07/2010CN1617733B Method of treatment of gastrointestinal disease and polymeric composition for use therein
04/07/2010CN1582921B Use and medicinal composition of eremophilane lactone for inhibiting hepatitis B virus
04/07/2010CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein
04/07/2010CN101691580A Novel fusion protein for human HMGB1 A box and acidic tail and use thereof
04/07/2010CN101691406A New fusion protein SSI, application and special gene thereof
04/07/2010CN101691405A Fusion antigen uses as vaccine
04/07/2010CN101691390A 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
04/07/2010CN101691367A Piperazine and <2,1-a> isoquinoline compounds with antifungal activity and salts thereof
04/07/2010CN101690821A Immune protective agent of attenuated living vaccine against infectious bursal disease and preparation method thereof
04/07/2010CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor
04/07/2010CN101690813A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof
04/07/2010CN101690812A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof
04/07/2010CN101690811A Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof
04/07/2010CN101690810A Tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu and preparation method thereof
04/07/2010CN101690809A Propolis-astragalus polysaccharides compound nanometer emulsion adjuvant and preparation method and application thereof
04/07/2010CN101690808A Method for preparing swine fever-pseudorabies bigeminal live vaccine and product thereof
04/07/2010CN101690807A Riemerella anatipestifer and escherichia coli bigeminal inactivated vaccine, and preparation method thereof
04/07/2010CN101690796A Traditional Chinese medicine composite for treating typhoid fever
04/07/2010CN101690791A Traditional Chinese medicine for treating epidemic encephalitis B
04/07/2010CN101690790A Drug for curing Japanese B encephalitis (JBE) in critical period
04/07/2010CN101690785A Bacteriostatic lotion and preparation method thereof
04/07/2010CN101690784A Traditional Chinese medicine for treating mycoplasma infection
04/07/2010CN101690783A External medicine for curing onychomycosis
04/07/2010CN101690772A Medicine for curing tuberculous pleuritis and eliminating pleural effusion
04/07/2010CN101690755A Antivirus extract and preparation method thereof
04/07/2010CN101690745A Chinese medicinal composition for preventing and treating flu
04/07/2010CN101690742A Application of radix hedysari in preparing medicament for treating animal infectious diseases
04/07/2010CN101690736A PRRSV and PCV2 co-infection mouse disease model
04/07/2010CN101690735A Complex microorganism health-protection agent and preparation method thereof
04/07/2010CN101690730A Method for quantum dot improvement and synchronous monitoring of antibacterial performance of ceftriaxone sodium
04/07/2010CN101690729A Application of montmorillonite in preparing medicament
04/07/2010CN101690721A Synthetic bamboo and wood vinegar, and production method and applications thereof
04/07/2010CN101690717A Valnemulin for livestock and saline premix and preparation method thereof
04/07/2010CN101690714A Antimicrobial, antiprotozoal and antitumor allicin liposome and preparation method thereof
04/07/2010CN101690712A Sitafloxacin eye drop and preparation method thereof
04/07/2010CN101690708A Cleaning and nursing solution for female pudenda and preparation method thereof
04/07/2010CN101690707A Cleaning and nursing solution for women in menstrual periods and preparation method thereof
04/07/2010CN101690640A Drug curtain cloth preventing influenza A H1N1 and preparation method
04/07/2010CN101041641B Di-diamino dihydrogen triazine derivative and preparation method and usage thereof
04/07/2010CN101032607B Medicine for treating pointed condyloma
04/07/2010CN101023945B Use of non-periphery substituted phthalocyaniu metal complex
04/06/2010US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes
04/06/2010US7691967 Smart pro-drugs of serine protease inhibitors
04/06/2010US7691899 non-peptide molecules, comprising side chains of amino acids, capable of adopting a helicoidal structure independent of the primary structure of the molecules; mimics active natural helices
04/06/2010US7691889 3-(substituted phenyl)-5-substituted-oxazolidin-2-ones; tuberculosis; e.g. (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-phenylbutanamide
04/06/2010US7691872 Administering compound that binds human serum albumin (HSA) to increase free drug levels of the camptothecin compound during anti-topoisomerase I-based therapy in human
04/06/2010US7691859 prenyl transferase inhibitors; e.g. 8-butyl-7-(3-(imidazol-5-yl)-1-oxopropyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine; antitumor agents; cancer of breast, colon, pancreas, prostate, lung, ovarian, epidermal; hematopoietics; Ras-dependent tumor;
04/06/2010US7691843 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example
04/06/2010US7691842 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors
04/06/2010US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi
04/06/2010US7691568 Antibody composition-containing medicament
04/06/2010US7691395 BASB119 polypeptide and polynucleotide from Moraxella catarrhalis
04/06/2010US7691393 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
04/06/2010US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics
04/06/2010CA2453383C Piperidine derivatives as nmda receptor antagonists
04/06/2010CA2399676C Pharmacologically active antiviral peptides and methods of their use
04/06/2010CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
04/06/2010CA2258675C 2-cyclopenten-1-one as an inducer of hsp70
04/06/2010CA2252466C Hepatitis b monoclonal antibodies
04/01/2010WO2010037046A1 Humanized neuraminidase antibody and methods of use thereof
04/01/2010WO2010036959A2 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
04/01/2010WO2010036945A2 Nanoemulsion therapeutic compositions and methods of using the same
04/01/2010WO2010036898A1 Compositions and methods for engineering probiotic yeast
04/01/2010WO2010036896A1 Hepatitis c virus inhibitors
04/01/2010WO2010036871A1 Macrocyclic compounds as hepatitis c virus inhibitors
04/01/2010WO2010036799A1 Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis "
04/01/2010WO2010036551A1 Hepatitis c virus inhibitors
04/01/2010WO2010036407A2 Antiviral nucleoside analogs
04/01/2010WO2010036399A2 Antiviral drugs for treatment of arenavirus infection
04/01/2010WO2010036362A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
04/01/2010WO2010035806A1 Solid pharmaceutical composition
04/01/2010WO2010035766A1 Method for producing triazole derivative
04/01/2010WO2010035722A1 Peptide compound and method for producing same
04/01/2010WO2010035253A1 Effective nitric oxide generating preparations
04/01/2010WO2010035148A1 Antiviral polypeptides
04/01/2010WO2010034812A1 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection
04/01/2010WO2010034671A1 Pyrine or pyrazine derivatives for treating hcv
04/01/2010WO2010034670A2 Host cell kinases as targets for antiviral therapies against hcv infection
04/01/2010WO2010034243A1 Novel gene cluster
04/01/2010WO2010034105A1 Hepatitis c inhibitor compounds
04/01/2010WO2010005836A9 Use of rifalazil to treat colonic disorders
04/01/2010WO2009142842A3 Novel macrocyclic inhibitors of hepatitis c virus replication
04/01/2010WO2009037592A3 Triazole-based aminoglycoside-peptide conjugates and methods of use
04/01/2010US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products
04/01/2010US20100081713 Compositions and methods for treating viral infections
04/01/2010US20100081711 Cytotoxic agents
04/01/2010US20100081700 Hepatitis C Virus Inhibitors
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081669 Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
04/01/2010US20100081658 Heterocyclic antiviral compounds
04/01/2010US20100081650 Antimicrobial Compounds
04/01/2010US20100081628 Nucleoside cyclicphosphates
04/01/2010US20100081627 Polymeric nucleoside prodrugs
04/01/2010US20100081623 Novel tellurium compounds and their use as immunomodulators
04/01/2010US20100081618 Transporters Comprising Spaced Arginine Moieties
04/01/2010US20100081609 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
04/01/2010US20100080844 Method to enhance an immune response of nucleic acid vaccination
1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 1798